Recombinant Anti-Human RANKL (Denosumab)

Specification
Target RANKL
Reactivities Human
Biosimilar Denbio
Isotype Human IgG1(E356D/M358L/A378S)-kappa
Property Antibody
Alternative AMG162;tumor necrosis factor (TNF) superfamily member 11, osteoclast differentiation factor, ODF, OPGL, RANKL, TRANCE, CD254,TNFSF11
Recommend Isotype
Formulation Buffer PBS, pH 7.4,Contains no stabilizers or preservatives
Recommend Buffer PBS, pH 7.4,Contains no stabilizers or preservatives.
Endotoxin <1EU/mg Determined by LAL gel clotting assay
Purity >95% Determined by SDS-PAGE
Sterility 0.2 μM filtered
Expression Host CHO
Purification method Protein A
Storage The product should be stored at the original stock concentration at 4°C. Avoid freeze-thaw cycles.
Note Due to the variability in applications, investigators should consult application references to estimate the appropriate dose or concentration. This dose or concentration can then be further optimized through experimental methods such as dose-response or titration experiments
Background
QC Data
Note Please contact us for QC Data
Product Image (Reference Only) antibody
$252.00
In stock
SKU
EB-EB25017

Recombinant Anti-Human RANKL (Denosumab) For Research Use Only

Question / Bulk Inquiry
Please leave us a message if you have any questions or have bulk order inquiry, we will get back to you in 24 hours.
Please type the letters and numbers below

 

Reviews

Write Your Own Review
You're reviewing:Recombinant Anti-Human RANKL (Denosumab)
Copyright © 2021-present Echo Biosystems. All rights reserved.